25 million worldwide
50–70 million US adults
264 million worldwide
280 million worldwide
400 million worldwide
75 million worldwide
160 million worldwide
55 million worldwide
We all know that music affects the way we feel.
X-System has modelled the way that patterns in music are processed by different parts of the human brain.
This enables us to select music to make targeted changes to electrical brainwave activity in individual patients.
Our first treatment is for intractable epilepsies – trademarked X-SEPT.
Certified as a Class 1 non-invasive medical device in the UK and EU.
A pilot study involving 20 severely epileptic patients, all of whom had continued to experience seizures despite pharmaceutical treatment, showed statistically significant results.
NHS England is currently trialling X-SEPT as a treatment for adults.
Explore the Research